No.
Myeloma is a condition in which plasma cells become cancerous. It is sometimes referred to as plasma cell dyscrasia or plasma cell myeloma, and most commonly as multiple myeloma (MM). Multiple myeloma is the most common form found in patients.
Lenalidomine is an oral cancer drug also known as Revlimid. It is used to treat all stages of multiple myeloma. It works in multiple ways to slow or kill myeloma cells.
He had two types of cancer - hairy-cell leukemia and multiple myeloma.
Smoldering multiple myeloma is a precursor condition to multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. In smoldering multiple myeloma, there are abnormal plasma cells present but they do not cause symptoms or organ damage. However, individuals with smoldering multiple myeloma are at a higher risk of developing active multiple myeloma, and close monitoring is required to detect any progression to the active disease. Treatment decisions for smoldering multiple myeloma are based on the risk of progression and may include observation or early intervention with therapy.
Sam Walton, the founder of Walmart, was treated for multiple myeloma at the M.D. Anderson Cancer Center in Houston, Texas. This facility is renowned for its cancer treatment and research. Walton's battle with the disease ultimately contributed to his passing in 1992.
There are many excellent sources of information on Myeloma and Multiple Myeloma available online. Some of these include the Myelmoa Foundation, the Leukemia & Lymphoma Society, and the American Cancer Society. Most national governments also have cancer information websites, such as America's National Institutes of Health.
Revlimid... "REVLIMID® is an oral medication that can stop or slow the growth of cancerous myeloma cells within the bone marrow. " "is the first of Celgene's new class of oral cancer drugs called IMiDs®. IMiDs are immunomodulatory agents (drugs that can modify or regulate the functioning of the immune system). IMiDs appear to have multiple actions, including both anticancer and anti-inflammatory activities. REVLIMID® (lenalidomide) in combination with dexamethasone is indicated for the treatment of multiple myeloma patients who have received at least one prior therapy." Here is a useful link: http://www.revlimid.com/multiple-myeloma/multiple-myeloma-home.aspx
Multiple myeloma is a cancer that affects plasma cells in the bone marrow, causing them to multiply abnormally and crowd out healthy blood cells. One of the key characteristics of multiple myeloma is the weakened bones due to the excessive activity of these abnormal plasma cells. Treatment for multiple myeloma aims to control the disease, relieve symptoms, and improve quality of life.
Reports I have read indicate some kind of blood cancer, perhaps multiple myeloma or leukemia.
Either Multiple Myeloma OR Chronic Myeloid Leukemia
There are no clearly-established risk factors for multiple myeloma and it is possible that a combination of factors interact to cause the disease. Thus, there is no method for preventing multiple myeloma.
Myeloma is a condition in which plasma cells become cancerous. It is sometimes referred to as plasma cell dyscrasia or plasma cell myeloma, and most commonly as multiple myeloma (MM). Multiple myeloma is the most common form found in patients.